Variable

6 week survival group (N = 86, 84.3%)

6 week mortality group (N = 16, 15.7%)

OR

95% CI

P Value

Age (years)^*

40 (30 - 57)

50 (26 - 60)

P = 0.8

Gender n (%)

Male

Female

68 (79.1)

18 (20.9)

11 (68.8)

5 (31.2)

0.85

0.18 - 1.96

P = 0.4

Etiology n (%)

Viral

Non-viral

49 (57)

37 (43)

9 (56.2)

7 (43.8)

0.97

0.33 - 2.85

P = 1

Comorbidity n (%)

Yes

No

12 (14)

74 (86)

3 (18.8)

13 (81.2)

P = 0.7

Hypovolemic shock n (%) Present

Absent

24 (27.9)

62 (72.1)

12 (75)

4 (25)

7.75

2.28 - 26.40

P = 0.001

Ascites n (%)

None/mild

Moderate/severe

53 (61.6)

33 (38.4)

2 (12.5)

14 (87.5)

11.24

2.4 - 52.7

P = 0.001

Encephalopathy n (%)

Present

Absent

19 (22.1)

67 (77.9)

7 (43.7)

9 (56.3)

2.7

0.9 - 8.3

P = 0.1

Active bleeding n (%)

12 (14)

4 (25)

2.06

0.6 - 7.4

P = 0.3

Clot on varix at endoscope n (%)

49 (57)

7 (43.8)

0.59

0.2 - 1.7

P = 0.5

Hb (mean ± SD)

7.7 ± 2.2

8.8 ± 2.2

P = 0.07

WBC^*

5.3 (2.9 - 8.3)

10.9 (6.8 - 15.5)

P < 0.0001

Platelets^*

86 (54.5 - 126.5)

122.5 (83 - 176.3)

P = 0.06

Albumin (g/dl)^*

2.8 ± 0.6

2.4 ± 0.5

P = 0.005

Bilirubin (mg/dl)^*

1.3 (0.8 - 2.9)

8.7 (1.4 - 19.1)

P < 0.0001

ALT^*

36 (22 - 55)

75.5 (37 -147)

P = 0.02

AST^*

42 (27.7 - 64.4)

116 (67.5 - 235.8)

P < 0.0001

Serum creatinine^*

0.8 (0.6 - 1)

0.9 (0.6 - 1.4)

P = 0.3

Serum Na^*

136 (132.8 - 139)

132 (130.3 - 136)

P = 0.04

INR^*

1.3 (1.2 - 1.6)

2.4 (1.7 - 3.2)

P < 0.0001

CPT score

7.5 (6.8 - 9)

11 (8 - 11)

P < 0.0001

CPT score

A

B

C

21 (24.4)

45 (52.3)

20 (23.3)

0 (0)

5 (31.2)

11 (68.8)

P = 0.001

MELD score^*

12.7 (9.3 - 16.2)

24.7 (19.8 - 31)

P < 0.0001

Systolic blood pressure^*

90 (80 - 100)

75 (0.0 - 87.5)

P < 0.0001